F.D.A.’s Approval of Drug for Autism Upends Review Process
- Posted on September 23, 2025
- Intellectual Disabilities
- By The New York Times
- 1 Views
F.D.A.’s Approval of Drug for Autism Upends Review Process
The agency revived an old treatment for cancer patients, unilaterally approving it for a subset of people with autism. Experts worry that the narrower scope will get lost in the hype. continue reading...
